Establish Treatment expectations and goals
Setting HAE treatment
HAE is a genetic, unpredictable, and lifelong condition, and it's important to set specific goals for therapy.
Choosing effective prevention with TAKHZYRO means working together with your patients to help prevent and reduce the severity of their HAE attacks—which may align with their treatment goals.
Create a regular check-in schedule to review progress and treatment goals—as routine monitoring is recommended by the 2020 HAEA guidelines.
Give TAKHZYRO 2.5 months to reach steady state (for patients age 12 and older)1
Encourage your patients to keep taking TAKHZYRO exactly as you prescribed. TAKHZYRO has a half-life of ~14 days, allowing it to be taken every 2 weeks. Because of this, it can take up to 6 doses (10 weeks) to reach steady state.1
Find suggestions for helping your patients stay on top of preventing HAE attacks with TAKHZYRO.Keep patients on track
HCP and patient resources
Find materials and forms to help get patients started on TAKHZYRO.See resources